Brought to you by:
JVS-VL to be open access beginning in January
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) will move from a subscription model to one of open access—freely available online—on Jan. 1, 2024. JVS-VL is the journal for both the SVS and the American Venous Forum (AVF)…
SVS members pitch in to help patients kick the smoking habit
SVS members are taking advantage of the new Smoking Cessation Toolkit and resources from the Vascular Quality Initiative (VQI), adding them to existing programs and giving new life to their quest to get their patients to kick the nicotine habit…
Ego, logistics, money: Overcoming barriers to a successful wound care program
Proper integration of primary care physicians (PCPs) in the multidisciplinary care of vascular wounds is going to play an increasingly important role as the popularity of the team approach spreads, according to a leading voice in the treatment of peripheral…
Society for Vascular Surgery addresses latest mainstream media reports on atherectomy
The Society for Vascular Surgery (SVS) has issued a statement addressing the latest reports published by ProPublica on atherectomy use in the U.S. The nonprofit investigative news outlet published three articles in its latest round of investigations looking into Medicare…
SVS receives CMSS grant to advance diagnostic excellence
The Society for Vascular Surgery (SVS) has received a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to promote diagnostic excellence across the medical field. The CMSS, a coalition of 53 specialty societies representing over 800,000 physicians, has…
Humacyte submits Biologics License Application to FDA seeking approval of Human Acellular Vessel
Humacyte today announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) seeking approval of the Human Acellular Vessel (HAV) in urgent arterial repair following extremity vascular trauma when synthetic graft is not…
Less vain and more vein: Evaluating the perceptions of venous disease amongst the vascular surgery community
Our biases permeate the fabric of our very being, as they weave their way into our training and practice. It is clear that complex aortic work is definitely in vogue and “in,” and, well… treating veins gets a bad rap.…
‘There is no reliable way to measure carotid stenosis—methods have changed and tend to overestimate the degree of narrowing’
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken by the Centers for Medicare & Medicaid Services (CMS). Two heavyweights in the stroke arena went…
Need for ‘clear, well-defined guidelines’ in patient selection for surgical implantation of baroreflex activation therapy devices identified
The emergence of a baroreflex activation therapy device for heart failure patients is drawing in the assistance of the open surgical expertise of vascular surgeons in the arena of the carotid bulb— and drawing attention to a need for “clear…
Bylaws referendum approved by SVS voting members
The voting members of the SVS have approved amendments to the Society bylaws following a referendum that closed on Nov. 20. The proposed changes were focused on two areas: adjustments to membership privileges for early-career members and adjustments to the…